|

IMM-H014 ( FE) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Changchun Intellicrown Pharmaceutical Co. LTD1

Indications

  • Nonalcoholic Steatohepatitis (NASH)1
  • Liver Disease1

Other1 trial

To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.